China’s life science investment market
Partnerships between China and Australia are strengthening the life sciences and taking the sector’s value to the next level.
China, Asia largest biopharma cluster, leads the way for R&D spending, companies, jobs and venture capital. The Chinese government has named the life sciences a priority sector, focusing on biopharma and advanced medical devices.